2025 Binaytara Global Oncology Summit conference hero image

2025 Binaytara Global Oncology Summit

Accreditation: 6.00 AMA PRA Category 1 Credit™ | 6.00 Nursing Contact Hours | 6.00 ABIM MOC II | 6.00 ACPE Pharmacy

Venue: Grand Hyatt Seattle, 721 Pine Street, Seattle, WA, 98101, United States

Start Date:

Official conference page for 2025 Binaytara Global Oncology Summit.

About 2025 Binaytara Global Oncology Summit

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Hemant Khandelia
28+

Faculty and committee

Conference program and agenda

Agenda

Saturday, November 1st, 2025

All timings are in Pacific Time (PDT, GMT-07:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits
08:00 AM - 08:15 AMWelcome & Opening Remarks
08:15 AM - 09:00 AMSession 1: Binaytara's Efforts

08:15 AM - 08:25 AM

Current Update of Binaytara's Mission Matt Lambert, MBA

08:25 AM - 08:35 AM

Abstract: OncoBlast: Bridging Global Cancer Education Gaps with Gamified Learning [email protected]

08:35 AM - 09:00 AM

Panel Discussion Jin Mou, MD, PhD, MPH; David Aboulafia, MD; Matt Lambert, MBA; Maeve Doolin, n/a

09:00 AM - 10:00 AMSession 2: Changing Politics & The Effects on Global Health

Session Chair: Pat Garcia-Gonzalez

09:00 AM - 09:15 AM

Keynote Lecture Pat Garcia-Gonzalez

09:15 AM - 09:25 AM

Abstract: Global Oncology Partnership to Improve Cancer Care in Nigeria: From Concept to Memorandum of Understanding in an LMIC Setting Daniel Ezekwudo, MD, PhD

09:25 AM - 10:00 AM

Panel Discussion Benjamin O. Anderson, MD, FACS; Edus Houston Warren, MD, PhD

10:00 AM - 10:30 AMBreak & Exhibits
10:30 AM - 12:00 PMSession 3: New Treatment Relevant to Global Health

Session Chair: Mazyar Shadman, MD, MPH

10:30 AM - 10:45 AM

Keynote: Using Immune Checkpoint Inhibitors to Reduce Global Cancer Mortality Shailender Bhatia, MD

10:45 AM - 11:00 AM

New Agents in CLL Mazyar Shadman, MD, MPH

11:00 AM - 11:15 AM

New Agents in GI Tumors William P Harris, MD

11:15 AM - 11:25 AM

Abstract: Socioeconomic characteristics and incidence of cytokine response syndrome (CRS), infections, cardiac and neurological toxicity of patients treated with chimeric antigen receptor (CAR) T cell therapy Himil Jignesh Mahadevia, MD

11:25 AM - 12:00 PM

Panel Discussion Vinod Pullarkat, MD

12:00 PM - 01:00 PMLunch & Exhibits
01:00 PM - 02:15 PMSession 4: Innovations

Session Chair: Cecilia CS Yeung, MD

01:00 PM - 01:15 PM

Keynote: Innovations in Molecular Diagnostics Cecilia CS Yeung, MD

01:15 PM - 01:30 PM

Molecular Diagnostics in Breast Cancer Jane Brock, MD

01:30 PM - 01:45 PM

Dried Blood Testing in CML Vivian G Oehler, MD

01:45 PM - 01:55 PM

Abstract: Edge Computing in Radiological Imaging: A Meta-Analysis of Accessibility for Cancer Detection in Low-Resource Settings Divyanshu Kumar

01:55 PM - 02:15 PM

Panel Discussion Ayokunle Olanrewaju, PhD; Jane E. Brock, MD, PhD; Vivian G Oehler, MD; Paul Lampe, PhD

02:15 PM - 03:15 PMSession 5: Public / Private Partnerships

Session Chair: Curt D. Malloy, JD, MPH

02:15 PM - 02:35 PM

Keynote: Primer on Public & Private Partnerships Curt D. Malloy, JD, MPH

02:35 PM - 02:50 PM

Unmet Need & Global Opportunity Cathyryne Manner, PhD

02:50 PM - 03:05 PM

Science Update and Target Product Profile of Breast Cancer Vaccine Peter Berglund, PhD

03:05 PM - 03:15 PM

Panel Discussion Adedamola Dada, MD

03:15 PM - 04:15 PMSession 6: Problems & Solutions on the Ground

Session Chair: Edus Houston Warren, MD, PhD

03:15 PM - 04:15 PM

Panel Discussion Manoj Agarwal, MD; Fengting Yan, MD

04:15 PM - 04:20 PMFinal Remarks & Adjourn

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing